Company Analysis

Artelo Biosciences, Inc. (ARTL)

Nasdaq: ARTL · Pharmaceutical Preparations · Solana Beach, CA · filing with the SEC since 2014
Grade4.6
◀ Past 4.6● Present 4.3▶ Future 4.8
6 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

2 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Artelo Biosciences, Inc.’s names, not what it holds today.

Patents granted
2
2 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
4
since 2001, to Dec 31, 2025
Names they are printed under
1
its own name
By yearGrantedApplications published
'19'20'21'22'23
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name1 counted
Artelo Biosciences, Inc. its own name
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in GB)
2 granted
4 published
Names not counted (1)
ARTELO BIOSCIENCES, INC.
Every patent under it that falls to this company prints another country (GB). 0 granted and 5 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jun 21, 202211,364,202Solid forms of cannabidiol and uses thereofPharmaceuticalsArtelo Biosciences, Inc.
Mar 31, 202010,604,467Solid forms of cannabidiol and uses thereofPharmaceuticalsArtelo Biosciences, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 21, 20232023/0404939SOLID FORMS OF CANNABIDIOL AND USES THEREOFPharmaceuticalsArtelo Biosciences, Inc.
Sep 30, 20212021/0299048SOLID FORMS OF CANNABIDIOL AND USES THEREOFPharmaceuticalsArtelo Biosciences, Inc. · patent 11,364,202 granted from it
Oct 3, 20192019/0300466NEW SOLID FORMS OF CANNABIDIOL AND USES THEREOFPharmaceuticalsArtelo Biosciences, Inc. · patent 10,604,467 granted from it
Jun 13, 20192019/0177258NEW SOLID FORMS OF CANNABIDIOL AND USES THEREOFPharmaceuticalsArtelo Biosciences, Inc.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ARTL · research, not advice